Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ADK | P55263 | 1/20 | 0.48 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.46 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29398412 | 1.00 | HIF1A (0.53) | HIF1AADKSLC29A1PIM1CSNK2A2 | |
| SCHEMBL13771420 | 0.89 | HIF1A (0.52) | HIF1AADKSLC29A1PIM1CSNK2A2 | |
| 2'-Deoxytubercidin SCHEMBL7872096 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| 2'-Deoxytubercidin SCHEMBL14294692 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| 2'-Deoxytubercidin SCHEMBL5918830 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| 2'-Deoxytubercidin SCHEMBL23982321 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| 2'-Deoxytubercidin SCHEMBL23982116 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| 2'-Deoxytubercidin SCHEMBL3229680 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 | |
| SCHEMBL20691354 | 0.87 | HIF1A (0.52) | HIF1AADKSLC29A1PIM1CSNK2A2 | |
| 2'-Deoxytubercidin SCHEMBL14104716 | 0.87 | METTL3 (0.57) | HIF1AADKADRB1DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230175030-A1 | NUCLEIC ACID POLYMER WITH AMINE-MASKED BASES | Nuclera Nucleics Ltd. (GB) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230175030-A1 | NUCLEIC ACID POLYMER WITH AMINE-MASKED BASES | RNGTT, POLM, POLRMT | HIF1A 2566/4885ADK 1146/4885SLC29A1 850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.